Stay updated on Savolitinib for MET Amplified Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The record displays details of the savolitinib study, including its terminated status, eligibility criteria, study design and outcomes, locations, and supporting documents.
    Difference
    68%
    Check dated 2026-11-09T13:44:15.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-02T13:33:51.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A site-wide banner announces updates and FAQs about NIH website changes, including a notice about terminology shifting from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T14:56:18.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision label changes from v3.7.1 to v3.7.2 while the page continues to show a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:42:49.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T15:36:19.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, signaling restricted access to the study record. The header shows a minimal navigation with a Home link and a revision note, replacing the previously accessible study content.
    Difference
    19%
    Check dated 2026-09-21T19:50:49.000Z thumbnail image

Stay in the know with updates to Savolitinib for MET Amplified Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Savolitinib for MET Amplified Colorectal Cancer Clinical Trial page.